Company intelligence / Profile preview
Advantice Health
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
Overview
Advantice Health markets a portfolio of science-backed over-the-counter therapeutic skincare brands. Their leading brands—AmLactin (moisturizers for dry skin), Kerasal/Kerasal Nail (foot/nail care), Triple Paste (diaper rash cream), Dermoplast (pain & itch relief spray), New Skin (liquid bandage/wound care), Emtrix/Zanmira—are widely available in retail stores and online. The company does not conduct clinical trials typical of prescription drug development but relies on established efficacy of its formulations for consumer use.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Small moleculeDeviceNon-pharmacological therapy
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Advantice Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Advantice Health.